30 August 2017 - - The global graft vs host disease treatment market to grow at a CAGR of 7.15% during the period 2017-2021, according to a report from Dublin-based Research and Markets.

Global Graft vs Host Disease Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts.

The report also includes a discussion of the Key vendors operating in this market. To calculate the market size, the report considers sales of branded, generic, and off-label drugs.

According to the report, one driver in the market is increased prevalence of cancer.

Globally, cancer is one of the life-threating diseases. As per National Institutes of Health, it is the second largest cause of death globally.

One trend in the market is inorganic growth strategies. The inorganic growth strategies are expected to contribute the growth of GVHD treatment market as the market is completely based on off-label usage.

These inorganic growth strategies include global merger and acquisition, partnerships and regional acquisition.

Key vendors include Bristol-Myers Squibb, Novartis, Pfizer and F. Hoffmann-La Roche.